[Is there still a role for tocolysis in treatment of threatened premature labor?].
作者信息
Spätling L
机构信息
Frauenklinik Städtisches Klinikum Fulda.
出版信息
Z Geburtshilfe Neonatol. 1997 Sep-Oct;201(5):182.
PMID:9440958
Abstract
摘要
相似文献
1
[Is there still a role for tocolysis in treatment of threatened premature labor?].[在先兆早产的治疗中，宫缩抑制剂是否仍有作用？]
Z Geburtshilfe Neonatol. 1997 Sep-Oct;201(5):182.
2
[Tocolysis].[宫缩抑制]
Z Geburtshilfe Neonatol. 1997;201 Suppl 1:25-9.
3
[Good sense and nonsense in tocolysis].[宫缩抑制中的合理与不合理之处]
Zentralbl Gynakol. 1995;117(6):300-3.
4
[In which pregnancy trimester is therapy with beta-mimetics of value? Beta receptor density in the course of pregnancy?].
Gynakologe. 1992 Jun;25(3):201.
5
[Beta-mimetic drug therapy: pro and contra].[β-拟似药物疗法：利弊]
Gynakol Geburtshilfliche Rundsch. 1993;33 Suppl 1:136-8. doi: 10.1159/000272193.
6
[Usefulness of beta mimetic treatment in threatened premature labor].β-拟似剂治疗先兆早产的效用
Rev Fr Gynecol Obstet. 1992 Jul-Sep;87(7-9):385-8.
7
[Medical tocolysis in threatening premature labor: what is safe in therapy?].[先兆早产的药物抑制宫缩治疗：何种治疗方法是安全的？]
Gynakologe. 1991 Aug;24(4):188-97.
8
Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.β2-肾上腺素能受体的精氨酸16纯合性可改善β2-激动剂用于早产保胎治疗后的结局。
Clin Pharmacol Ther. 2005 Dec;78(6):656-63. doi: 10.1016/j.clpt.2005.08.021.
9
[Tocolytic therapy in breech presentation and threatened premature labor].
Z Geburtshilfe Neonatol. 1997 May-Jun;201(3):201.
10
[What treatment in threatened premature labor?].[先兆早产如何治疗？]
Rev Fr Gynecol Obstet. 1992 Jul-Sep;87(7-9):388, 391.
Zotero 插件